中西医联合治疗JAK2V617F阳性原发性血小板增多症的临床疗效

Clinical curative effect of combined traditional chinese and western medicine in the treatment of positive JAK2V617F primary thrombocytosis

目的:探讨中西医联合治疗JAK2V617F阳性原发性血小板增多症的临床疗效。方法:将住院与门诊收治的JAK2V617F阳性原发性血小板增多症患者56例作为研究对象,随机分为对照组(27例)和实验组(29例),对照组患者接受α-干扰素进行治疗,实验组患者在对照组治疗基础之上加用中药汤剂进行治疗,对比两组患者药效临床有效率及血小板计数减少程度。结果:两组患者临床有效率、血小板计数减少对比,差异均有统计学意义(P<0.05)。结论:临床可对JAK2V617F阳性原发性血小板增多症进行中西医联合治疗,疗效满意,不良反应少且不易复发。

Objective:Discussion of Chinese and western medicine combined treatment the clinical curative effect of positive JAK2V617F primary thrombocytosis.Methods:Will be to the Hospital in the outpatient service of 56 patients with positive JAK2V617F primary thrombocytosis as the research object,were randomly divided into control group(n=27)and experimental group(n=29)and control group accepted alpha interferon treatment,based on trial group used alpha interferon plus one treated with Chinese traditional medicine,clinical effect of efficient and low platelet count of the two groups of patients was compared.Results:clinical effectiveness,low platelet count contrast of the two groups exists obvious difference(P<0.05).Conclusion:In clinical practice,positive JAK2V617F primary thrombocytosis can be treated with combined Chinese and western medicine,which proves satisfying curative effect with less adverse reaction and relapse.